Pegfilgrastim

Neulasta and neupogen are similar molecules.

The primary difference is that Neulasta has a PEG (polyehtylene glycol) incorporated in its composition, thereby lengthening its duration of action. As a result, Neulasta is administered on a less frequent schedule. It is typically injected once for each cycle of high-dose chemotherapy 24 hours after chemo and no sooner than 14 days before your next chemo treatment.

Neupogen is typically injected on a daily basis until your neutrophil counts come back to normal levels. Neupogen may work fine with just weekly chemo treatments or it may be given as often as you need between chemo cycles. Neulasta and neupogen are similar molecules.

The primary difference is that Neulasta has a PEG (polyehtylene glycol) incorporated in its composition, thereby lengthening its duration of action. As a result, Neulasta is administered on a less frequent schedule. It is typically injected once for each cycle of high-dose chemotherapy 24 hours after chemo and no sooner than 14 days before your next chemo treatment.

Neupogen is typically injected on a daily basis until your neutrophil counts come back to normal levels. Neupogen may work fine with just weekly chemo treatments or it may be given as often as you need between chemo cycles.

These medications are prescribed for breast cancer patients who are at risk of decreased number of neutrophils (type of white blood cell) from the cancer or specific treatment
These medications are prescribed for breast cancer patients who are at risk of decreased number of neutrophils (type of white blood cell) from the cancer or specific treatment

Common side effects of Neupogen (Filigrastim) are:
- redness, swelling, bruising, itching or a lump in the location where the medication was injected
- bone, joint, or muscle pain
- headache
- nosebleeds

The following potential serious side effects should be reported to your physician: fever or chills, unhealed sores, swelling of extremities, difficulty breathing such as shortness of breath or trouble breathing, or chest pain and palpitations.
Common side effects of Neupogen (Filigrastim) are:
- redness, swelling, bruising, itching or a lump in the location where the medication was injected
- bone, joint, or muscle pain
- headache
- nosebleeds

The following potential serious side effects should be reported to your physician: fever or chills, unhealed sores, swelling of extremities, difficulty breathing such as shortness of breath or trouble breathing, or chest pain and palpitations.

Neupogen (Filgrastim) and Neulasta (Pegfilgrastim) are medications prescribed to patients with low white blood cell counts.

These medications are natural proteins which help stimulate the bone marrow to produce white blood cells. Neulasta has a "PEG" (polyehtylene glycol) added to the molecule making it last longer in your body than Neupogen. Neupogen (Filgrastim) and Neulasta (Pegfilgrastim) are medications prescribed to patients with low white blood cell counts.

These medications are natural proteins which help stimulate the bone marrow to produce white blood cells. Neulasta has a "PEG" (polyehtylene glycol) added to the molecule making it last longer in your body than Neupogen.

Neutropenia is a low neutrophil count. Neutrophils are a type of white blood cell that protects the body from infections caused by bacteria and fungi. Neutropenia results in a weak immune system which increases the risk of an infection.

Neutropenia is a potential side effect of chemotherapy treatments and radiation therapy. Chemotherapy medications attack healthy cells as well as cancer cells and this includes attacking white blood cells.

At risk patients of neutropenia should be watched very closely for fevers and other signs of infection. Neutropenia may be diagnosed from a blood cell count.

If you have neutropenia, your doctor may need to delay chemo treatment or reduce your chemotherapy dose until your white blood cell count increases and the possibility of infection is diminished.
Neutropenia is a low neutrophil count. Neutrophils are a type of white blood cell that protects the body from infections caused by bacteria and fungi. Neutropenia results in a weak immune system which increases the risk of an infection.

Neutropenia is a potential side effect of chemotherapy treatments and radiation therapy. Chemotherapy medications attack healthy cells as well as cancer cells and this includes attacking white blood cells.

At risk patients of neutropenia should be watched very closely for fevers and other signs of infection. Neutropenia may be diagnosed from a blood cell count.

If you have neutropenia, your doctor may need to delay chemo treatment or reduce your chemotherapy dose until your white blood cell count increases and the possibility of infection is diminished.